The US Food and Drug Administration has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in adults.

Discover effective supplements for migraine prevention and learn who should or shouldn't use them. Explore evidence-based ...

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

A 2024 review compared 17 medications for treating acute migraine headaches to see which are most effective in relieving pain. It showed that all active medications worked better than a placebo ...

Wondering how to talk to a doctor about migraine? An expert discusses common questions for your doctor to help diagnose ...

But understanding what happens in your brain during an attack can help manage the condition better and empower them. A ...

Ginger is known for its soothing effects on the stomach, and can effectively relieve nausea. It may also play a role in ...

Migraine is a common neurological syndrome that affects approximately 10–20% of the population. The pathophysiology of migraine is unclear. 5-hydroxytriptamine is a key mediator in the ...

Expert Rev Clin Pharmacol. 2013;6(3):271-288. Triptans are highly effective for short-term treatment of acute migraine attacks. They are effective in MA or MO, but are not intended for use in ...

Axsome Therapeutics, Inc. (NASDAQ:AXSM) signed a settlement agreement with Teva Pharmaceuticals Inc (NYSE:TEVA). The ...

Recently, the FDA approved Axsome Therapeutics’ Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in adults. “Axsome is our top pick for 2025 ...